Michael DeBaun Archive — Page 1 of 2

May 26, 2026

Research Week 2026: Celebrating innovation and excellence in pediatric medicine

From thought-provoking lectures to data-driven presentations, Research Week provided a platform for researchers to share their discoveries, inspire collaboration and ignite new ideas to improve the lives of children everywhere. 

(photo by Erin O. Smith)
December 4, 2025

Vanderbilt-Ingram researchers present cancer advancements at ASH 2025 

Established in 1958, ASH is the world’s largest professional organization for clinicians and scientists who study blood diseases. 

Michael R. DeBaun, MD, MPH
August 19, 2025

Vanderbilt’s Michael R. DeBaun elected to American Academy of Arts and Sciences

This year, 247 members were elected from the mathematical, physical, biological, social and behavioral sciences, humanities, the arts, leadership, policy and communications.

(iStock)
February 27, 2025

VUMC part of new study validating curative therapy for sickle cell disease

Of 38 adults with severe SCD who participated in the study, more than 97% no longer required immunosuppressive therapy one year after the transplant.

June 25, 2024

International trial introduces another curative option for sickle cell disease 

The therapy, haploidentical bone marrow transplant with thiotepa and posttransplant cyclophosphamide, is as safe and more affordable than the recently FDA-approved myeloablative gene therapy and gene editing treatments.

Michael R. DeBaun, MD, MPH
February 29, 2024

Michael DeBaun receives Paragon Award from the Doris Duke Charitable Foundation

Vanderbilt’s Michael DeBaun, MD, MS, MPH, has received the Paragon Award for “Innovative Improvements to Clinical Care or Healthcare Delivery” from the Doris Duke Charitable Foundation (DDF).